New Oral Drug Offers Diabetes and Weight Loss Treatment Without Muscle Loss

Innovative Approach to Diabetes and Obesity Treatment

Scientists are developing alternative treatments to GLP-1 drugs like Ozempic and Wegovy that can aid weight loss and manage type 2 diabetes without causing muscle loss. A recent study from Sweden introduces an oral medication that works by activating muscle metabolism, thereby preserving muscle mass during weight reduction.

This new drug, based on a beta-2 molecule, was tested in a Phase 1 clinical trial involving healthy individuals and those with type 2 diabetes. Participants tolerated the medication well, with only mild and temporary increases in heart rate observed early in the trial. No significant changes in blood pressure or heart health were noted, and adverse events were limited.

The promising results suggest this drug could help maintain metabolic rate and blood sugar regulation, both of which are impacted by muscle loss in traditional weight-loss drugs. The next phase will evaluate long-term effects on muscle mass, glucose control, and insulin sensitivity.

Experts highlight the importance of preserving muscle to improve outcomes in weight and diabetes management. The development of this medication could address major side effects of current treatments and improve patient health in the long term.